Skip to content
  • Home
  • News
  • Videos
  • Conference Coverage
  • Podcasts
  • Resource Centers
    • Acne
    • Skin Cancer
    • Alopecia
    • Atopic Dermatitis
    • Cosmetics
    • Hidradenitis Suppurativa (HS)
    • Pediatrics
    • Pigment Disorders
    • Practice Management
    • Psoriasis
    • Rare Diseases
    • Rosacea
    • Vitiligo
  • Home
  • News
  • Videos
  • Conference Coverage
  • Podcasts
  • Resource Centers
    • Acne
    • Skin Cancer
    • Alopecia
    • Atopic Dermatitis
    • Cosmetics
    • Hidradenitis Suppurativa (HS)
    • Pediatrics
    • Pigment Disorders
    • Practice Management
    • Psoriasis
    • Rare Diseases
    • Rosacea
    • Vitiligo
Subscribe

US FDA Grants QRX003 Rare Pediatric Disease Designation for Peeling Skin Syndrome

The US Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) Designation for Quoin Pharmaceuticals Ltd’s QRX003 for the treatment of Peeling Skin Syndrome (PSS).

The Dermatology Digest is an independent, multi-channel resource for practicing dermatologists and dermatological practitioners.

Quick Links
  • Advertise with Us
  • About Us
  • Advertise with Us
  • About Us
Follow us
Linkedin Facebook-f X-twitter Youtube

© 2026 All Rights Reserved.